Optimized threshold for serum HCV RNA to predict treatment outcomes in hepatitis C patients receiving peginterferon alfa-2a/ribavirin. [electronic resource]
Producer: 20130225Description: 766-74 p. digitalISSN:- 1365-2893
- Adult
- Alanine Transaminase -- blood
- Antiviral Agents -- therapeutic use
- Drug Therapy, Combination
- Female
- Hepacivirus -- genetics
- Hepatitis C -- drug therapy
- Humans
- Interferon-alpha -- therapeutic use
- Logistic Models
- Male
- Middle Aged
- Polyethylene Glycols -- therapeutic use
- RNA, Viral -- blood
- ROC Curve
- Recombinant Proteins -- therapeutic use
- Retrospective Studies
- Ribavirin -- therapeutic use
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.